Vycor Medical (VYCO) Notes Payables (2010 - 2026)

Vycor Medical (VYCO) has reported Notes Payables for 17 consecutive years, with $303674.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Notes Payables changed 0.2% year-over-year to $303674.0 in Q2 2026; TTM through Jun 2026 was $303674.0, a 0.2% change from a year earlier, with the FY2025 full-year figure at $326978.0, up 0.86% from the prior year.
• Notes Payables was $303674.0 for Q2 2026 at Vycor Medical, down from $312920.0 in the prior quarter.
• Over five years, Notes Payables peaked at $430873.0 in Q3 2022 and troughed at $303074.0 in Q2 2025.
• A 5-year average of $334028.8 and a median of $324448.0 in 2022 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables grew 27.2% in 2022 and slipped 24.31% in 2023, its largest moves.
• Over 5 years, Notes Payables stood at $324711.0 in 2022, then increased by 1.1% to $328267.0 in 2023, then slipped by 1.24% to $324185.0 in 2024, then increased by 0.86% to $326978.0 in 2025, then declined by 7.13% to $303674.0 in 2026.
• The last three Notes Payables figures came in at $303674.0 (Q2 2026), $312920.0 (Q1 2026), and $326978.0 (Q4 2025), per Business Quant data.